A sensitive method for determining exposure to the chemical warfare agent VX is described in which the biomarker ethyl methylphosphonofluoridate (VX-G) is measured in red blood cells (RBCs) following treatment with fluoride ion using isotope-dilution gas chromatography-tandem mass spectrometry. The analyte was isolated via solid-phase extraction and detected using ammonia chemical ionization in the multiple reaction monitoring mode. A good linear relationship was obtained in the quantitative concentration range of 4 ng/mL to 1000 ng/mt with an absolute detection limit of < 1 pg on column. The method has been applied to the analysis of RBCs from a laboratory worker accidentally exposed to VX vapor. Detection and quantitation of VX-G were possible in samples taken as late as 27 days following exposure.
Introduction
O-Ethyl-S-[2-(diisopropylamino)ethyl methylphosphonothioate (VX) is an extremely toxic organophosphate chemical warfare nerve agent. Exposure to VX can result in a variety of toxicological effects with the most severe resulting in death. The toxicity of organophosphate nerve agents results from their effects on enzymes, particularly esterases. The most notable of these esterases is acetylcholinesterase, where the nerve agent phosphorylates a serine hydroxyl group in the active site of the enzyme, thus inhibiting the cholinesterase from hydrolyzing the neurotransmitter acetylcholine (1) . Clinical effects manifested after exposure to these cholinesterase inhibitors depend on the route, such as inhalation or percutaneous exposure and the amount of exposure. These signs or symptoms may include miosis due to contraction of pupillary sphincter muscles, tearing and salivation due to excess secre-tions of the exocrine glands, and twitching of large muscle groups due to hyperactivity in skeletal muscle (2) .
Studies documenting human exposures to VX have been limited mainly to early military investigations (3) (4) (5) (6) , where volunteer subjects were administered sub-lethal doses of VX and monitored for signs and symptoms of anticholinesterase poisoning, including blood cholinesterase activity. More recently, metabolites of VX were identified in the serum collected from a victim of VX poisoning in Osaka, Japan (7) . In this latter study, ethyl methylphosphonic acid a known hydrolysis product of VX (8) was detected and quantitated along with 2-(disopropylaminoethyl)methyl sulfide (DAEMS). The DAEMS was postulated to arise from enzymatic methylation of 2-(diisopropylamino)ethanethiol, an additional hydrolysis product of VX.
In addition to these traditional techniques for assessing exposure to VX, several researchers have demonstrated the utility of a fluoride ion regeneration method (9, 10) for the production of the biomarker ethyl methylphosphonofluoridate (VX-G) from human serum exposed to VX. Jakubowski et al. (11) showed the method to be both selective and sensitive with a method detection limit of 10.5 pg of agent on column using gas chromatography (GC) with a flame-photometric detector. Degenhardt et al. (12) analyzed extracts from the fluoride reactivation of human plasma samples that had been inhibited with VX by incubation via GC with high-resolution mass spectrometry (MS) and reported minimum measurable levels of VX-G as 3 pg/mL corresponding to 3 pg of agent on column for a 1-mL human plasma sample. Using GC with tandem MS, this fluoride ion regeneration technique was applied to the analysis of rat plasma exposed to VX and shown to be even more sensitive, with detection limits of < 1 pg of VX-G on column (13) .
Recently, we applied the fluoride ion regeneration technique to the analysis of red blood cells collected from an individual accidentally exposed to VX vapor. The method employs GC-MS-MS on a triple-quadrupole MS using stable isotope dilution for quantitation. Results indicated that even 27 days after exposure measurable quantities of VX-G were detected.
Experimental

Chemicals and reagents
Ethyl methylphosphonofluoridate (VX-G, Figure 1 ) of purity greater than 97% and 2Hs-ethyl methylphosphonofluoridate (deuterated VX-G, Figure 2 ) of isotopic purity greater than 95% were procured from the Edgewood Chemical Biological Center (Aberdeen Proving Ground, MD). Potassium fluoride, 2-propanol, ethyl acetate, glacial acetic acid, and anhydrous sodium sulfate were all obtained from Sigma-Aldrich (St. Louis, MO) at > 99% purity. Sodium acetate was purchased from Fischer Chemicals (Fair Lawn, N J) at > 99% purity. Ammonia and methane were obtained from Sigma-Aldrich, while helium and argon were obtained from Messer (Malvern, PA). All gases had purities > 99.9%.
Stock solutions and calibration standards preparation
Stock solutions of VX-G and deuterated VX-G were prepared in ethyl acetate at concentrations of 2.048 mg/mL and 1.203 mg/mL, respectively, and stored at -20~ until used. Individual working solutions (nominally 50 pg/mL each) were prepared by diluting stock solutions in ethyl acetate for optimization of chromatographic and MS conditions. Calibration standards of VX-G were prepared by diluting the working solution to obtain the following 10 concentration points: 4, 10, 25, 50, 100, 200, 400, 600, 800, and 1000 ng/mL. Each calibration standard also contained 1000 ng/mL deuterated VX-G diluted from the working solution. All of the calibration standards were also stored at -20~ until analysis. Figure 3 shows the response of VX-G to the internal standard (deuterated VX-G), with response being defined as Areavx.c x (Conqs/Areals) as a function of picograms VX-G injected onto the column. These data are an average taken over the course of five weeks with n = 10 and show good correlation (r 2 = 0.9979) over two orders of magnitude.
Analytical method
The assay was performed using an Agilent Technologies GC model 6890 (Wilmington, DE) interfaced to a Waters Micromass Quattro micro GC TM tandem quadrupole MS (Milford, MA). GC separations were achieved using a Restek jector port at a temperature of 225~ The initial oven temperature of 35~ was held for 2 rain, then ramped at 15~ to 125~ then 30~ to 325~ Elution times for both VX-G and deuterated VX-G were typically 5 min.
Samples were ionized by positive-ion chemical ionization (CI) with ammonia reagent gas. CI source conditions were optimized using Fluoroether E3 (CAS Registry Number reagent gas. Mass spectra were obtained at a dwell time of 0.05 s for each transition in the multiple reaction monitoring (MRM) mode. Argon was used as the collision gas at a pressure of ~2 mTorr, with a collision-induced dissociation (CID) energy of 10 eV. The CID energy was optimized for the m/z 144 > 99 transition for VX-G and the m/z 149 > 100 transition for deuterated VX-G. Typical CID mass spectra obtained in our laboratory are shown in Figure 4 . The MassLynx application software provided with the Quattro micro GC was used to process and analyze the data. The Quanlynx software provides automated peak detection, calibration, and quantification.
Sample preparation
Sample preparations for this study were similar to those published by Jakubowski et al. (10) for fluoride ion released sarin. Whole blood samples obtained with informed consent from the patient were collected in glass evacuated blood collection tubes containing K3EDTA. The blood samples were separated into RBC and plasma fractions by centrifugation at 4500 rpm for 10 min at 10~ using an Allegra 25R centrifuge (Beckman Coulter, Palo Alto, CA). Following centrifugation, the plasma fraction was removed and immediately stored at -70~ and the RBC fraction was refrigerated until analyzed. Red blood cell samples were extracted for VX-G using SepPak | Vac 3-cc C18 solid-phase extraction (SPE) cartridges (200 mg, Waters, Milford, MA) which were first conditioned with I mL each of ethyl acetate, 2-propanol, and then pH 3.5 acetate buffer (0.01M sodium acetate, 0.2M glacial acetic acid). To a weighed sample of RBCs (0.2-0.5 g) in a 2.0-mL microcentrifuge tube (Sigma-Aldrich, St. Louis, MO), 1 mL of acetate buffer, 200 IJL of KF solution (6M), and 1 IJL of internal standard, deuterated VX-G, were added. The mixture was vortex mixed for 10-20 s and then centrifuged at 15,000 rpm for 5 rain using a Micromax Microcentrifuge (Thermo IEC, Needham Heights, MA). Following transfer of the supernantant liquid to the SPE cartridge, the sediment at the bottom of the microcentrifuge tube was resuspended with 750 taL of acetate buffer and 200 IJL of KF solution. This mixture was also vortex mixed and centrifuged and the resulting liquid added to the original solution. Fifteen minutes after the original addition of acetate buffer and KF, the combined reaction mixture was allowed to drain through the SPE cartridge under a gentle vacuum. The analytes were eluted with I mL of ethyl acetate that was collected and dried over anhydrous sodium sulfate. The ethyl acetate was withdrawn from the collection tube and filtered through a 0.2-1am nylon Acrodisc | syringe filter (Pall Gelman Laboratory, Ann Arbor, MI) into a GC autosampler vial (Agilent Technologies, Wilmington, DE) where it was concentrated to 50 IJL for analysis.
Method validation
Although the method described herein was not fully validated using human red blood cells, the fluoride ion regeneration assay for VX-G in both plasma and red blood cell fractions from animal studies employing rats (14) , guinea pigs, and minipigs (15) has been successfully implemented in our laboratory. In the case of minipigs (a typical mammalian animal model), typical RBC matrix spikes at nominal levels of 10, 200, and 1000 ng/mL yield RSDs of _+ 20.7, 4.6, and 3.8%, respectively. The limit of quantitation has been demonstrated at 5 pg on column.
Results and Discussion
Case history
On June 1, 2006, a laboratory worker noticed dimness of vision and a feeling of tightness in the chest while performing routine laboratory work in an area where no known chemical warfare nerve agent operations were to have occurred. Following standard operating procedures, the laboratory worker and fellow employees performed self-decontamination and immediately contacted emergency response personnel. Because the lab worker exhibited early clinical signs of nerve agent intoxication, one MARK I nerve agent antidote kit (600 mg pralidoxime chloride and 2 mg atropine) was administered, and the worker transported to a local hospital for observation. The patient initially reported symptoms that included tightness in the chest and difficulty breathing that was later followed by blurry vision, miosis, mild rhinorrhea, and eyelid muscle fasciculations. No significant depression in blood cholinesterase activity was reported. All symptoms disappeared within 24 h of the exposure.
After consulting other laboratory workers who were in the same area and who did not have signs or symptoms of exposure, it was determined that agent vapors could have originated in the room from a drying oven containing glassware that was cleaned after having been previously contaminated with VX. As compared to other workers who were in and out of the same area, the exposed worker was sitting closest to the oven for the longest period of time. Subsequent air monitoring of the laboratory at several locations in the room including where the exposed worker was sitting confirmed the presence of VX vapor with the highest concentration [0.000026 mg/m 3, 8-h timeweighted average (TWA)] reported in the room nearest the drying oven. This is significantly higher than the most recently recommended worker population limit (WPL) expressed as an 8-h TWA of 0.000001 mg/m 3 (16) . Furthermore, the actual vapor concentration during the exposure incident (approximately 90-120 rain) was probably higher than 26 x WPL because the drying oven was turned off before the air samples were collected for safety reasons.
GC-MS-MS analysis of red blood cell samples
Because it has been shown that VX appears to inhibit red blood cell cholinesterase preferentially over plasma cholinesterase (5, 17) , efforts in our laboratory have focused on assessing exposure to VX via fluoride ion regeneration primarily by analyzing the RBC fraction of whole blood. Red blood cell samples were obtained from the exposed laboratory worker on days 1, 6, 8, 20 , and 27 following the inhalation exposure. Figure 5 shows the chromatographic trace obtained for the m/z 144 > 99 transition from the analysis of the red blood cell sample taken I day post exposure. The on column amount of VX-G was calculated to be 7.7 pg with a signal-to-noise RMS of 25.4:1. This calculates to a concentration of 242.1 pg/mL in the RBC sample. Previous work (15) possibly 120 rain (Ct = 1.5 rag-rain/m3), and a VX-G concentration of 219.9 + 97.1 pg/mL was detected in the RBC sample taken 1 day post exposure. Typical recoveries from spiked quality control samples using minipig red blood cells average between 110 and 120% (data not shown). Assuming the average concentration of acetylcholinesterase in the red blood cells is 3nM (18) and the total amount of VX-G determined is from enzyme-bound regenerated agent, the VX-G concentrations shown in Table I could account for as high as a 70% depression in the acetylcholinesterase activity. However, because no significant depression in blood cholinesterase activity was reported in the laboratory worker the source of the VX-G is most likely either free VX (which would be converted to VX-G under the conditions of sample preparation) or regenerated agent from bound sites other than the cholinesterase enzyme. Figure 6 shows the average VX-G concentrations as a function of time during which the samples were taken following the VX exposure. These data were fitted to a simple two parameter exponential decay equation (shown as a solid line) in order to approximate the half-life of the fluoride ion regenerated biomarker VX-G. With a correlation coefficient of 0.6913, the t~ was calculated to be 24.5 days, indicating that even several weeks after a low-level exposure to VX, detection and quantitation of VX-G should be possible.
Conclusions
The fluoride ion regeneration method has been shown to be an effective technique for producing the biomarker VX-G from human red blood cells following exposure to VX. Using isotopedilution GC-MS-MS the target analyte can be detected and quantitated in samples taken as late as three weeks postexposure. For retrospective detection following a potential nerve agent exposure, this approach could be used even in the absence of gross clinical signs or when treatment, such as oxime therapy, has begun.
